Patients & Disease Areas Focus

Ongoing Trials

A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma (ASN-002-001)

Therapeutic area:
Oncology; Oncodermatology
Status:
Completed
Study ID:
ASN-002-001 (NCT02550678)

Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Therapeutic area:
Oncology; Oncodermatology
Status:
Recruiting
Study ID:
ASN-002-003 (NCT04416516)

For more information on our trials, visit www.clinicaltrials.gov